(Bloomberg) — Formula isn’t just for babies. April Crohare desperately needs it for her 14-year-old son, Charlie. Due to medical complications from a rare brain disorder called lissencephaly, his only ...

Michael Sansoterra is the chief investment officer, managing director and senior portfolio manager at Silvant Capital Management, an affiliate of Virtus Investment Partners. Based out of Atlanta, Ga., ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

A 10-year follow-up study suggests that infants with high hemoglobin levels who received iron fortified infant formula have poorer long-term developmental outcomes, according to a new report. "The ...

Formula isn’t just for babies. April Crohare desperately needs it for her 14-year-old son, Charlie. Due to medical complications from a rare brain disorder called lissencephaly, his only source of ...